Cytokinetics, Incorporated (CYTK)

Cytokinetics Stock Forecast

Stock Price Forecast

The 16 analysts that cover Cytokinetics stock have a consensus rating of "Strong Buy" and an average price target of $78.94, which forecasts a 25.86% increase in the stock price over the next year. The lowest target is $41 and the highest is $120.

Price Target: $78.94 (+25.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$41	$78.94	$82	$120
Change	-34.63%	+25.86%	+30.74%	+91.33%

Analyst Ratings

The average analyst rating for Cytokinetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	5	5	5	6
Buy	7	7	9	9	8	8
Hold	3	3	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	16	16	15	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Paul Choi Goldman Sachs	Goldman Sachs	Hold → Strong Buy Upgrades $55 → $95	Hold → Strong Buy	Upgrades	$55 → $95	+51.47%	Dec 19, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $72	Strong Buy	Reiterates	$72	+14.80%	Dec 12, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $82 → $87	Buy	Maintains	$82 → $87	+38.71%	Nov 11, 2025
Mayank Mamtani B. Riley Securities	B. Riley Securities	Strong Buy Reiterates $80 → $90	Strong Buy	Reiterates	$80 → $90	+43.49%	Nov 10, 2025
Gena Wang Barclays	Barclays	Buy Maintains $71 → $82	Buy	Maintains	$71 → $82	+30.74%	Oct 6, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

85.23M

Increased by 361.33%

from 18.47M

Revenue Next Year

140.74M

Increased by 65.14%

from 85.23M

EPS This Year

-6.48

from -5.26

EPS Next Year

-5.76

from -6.48

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	55.83M	70.43M	94.59M	7.53M	18.47M	85.23M	140.74M
Revenue Growth	107.79%	26.15%	34.31%	-92.04%	145.34%	361.33%	65.14%
EPS	-1.97	-2.80	-4.33	-5.45	-5.26	-6.48	-5.76
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	22	20

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	161.5M	245.7M
Avg	85.2M	140.7M
Low	68.6M	53.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	774.3%	188.3%
Avg	361.3%	65.1%
Low	271.3%	-37.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-5.20	-4.70
Avg	-6.48	-5.76
Low	-7.05	-6.67

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.